Welcome to the webpage of www.aml-score.org

This webpage contains two online tools to estimate the prognosis in patients with acute myeloid leukemia (AML).

AML-Score calculates the chance of achieving a complete remission (CR) and the risk of early death within 60 days after an intensive induction therapy in patients of 60 years of age or older with previously untreated AML.

The PINA scores can be used to assign previously untreated adult patients with AML of normal karyotype to groups with different overall survival or relapse-free survival.

These scores are based on pre-therapeutic clinical and molecular parameters. The scores herein are calculated according to the underlying algorithms as published [1,4].